Lassa fever causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 23: Line 23:
==Virus==
==Virus==
===Taxonomy===
===Taxonomy===
[[Viruses]]; [[ssRNA viruses]]; [[ssRNA negative-strand viruses]]; [[Arenaviridae]]; [[Mammarenavirus]] <ref>{{cite web | title = Taxonomy browser (Lassavirus) | url = http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=11621&lvl=3&keep=1&srchmode=1&unlock&lin=s}}</ref>
* [[Viruses]]; [[ssRNA viruses]]; [[ssRNA negative-strand viruses]]; [[Arenaviridae]]; [[Mammarenavirus]] <ref>{{cite web | title = Taxonomy browser (Lassavirus) | url = http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=11621&lvl=3&keep=1&srchmode=1&unlock&lin=s}}</ref>
 
===Biology===
===Arenaviridae===
* Lassa virus belongs to Arenaviridae <ref name=NCCN>{{cite web | title = The Centers for Disease Control and Prevention | url =http://www.cdc.gov/vhf/virus-families/arenaviridae.html }}</ref>.
* Lassa virus belongs to Arenaviridae <ref name=NCCN>{{cite web | title = The Centers for Disease Control and Prevention | url =http://www.cdc.gov/vhf/virus-families/arenaviridae.html }}</ref>.
* The Arenaviridae are a family of [[viruses]] whose members are generally associated with rodent-transmitted diseases in [[humans]]. Each [[virus]] usually is associated with a particular [[rodent]] host species in which it is maintained. [[Arenavirus]] infections are relatively common in humans in some areas of the world and can cause severe [[illnesses]].
* The Arenaviridae are a family of [[viruses]] whose members are generally associated with rodent-transmitted diseases in [[humans]]. Each [[virus]] usually is associated with a particular [[rodent]] host species in which it is maintained. [[Arenavirus]] infections are relatively common in humans in some areas of the world and can cause severe [[illnesses]].
* The [[virus]] particles are [[spherical]] and have an average diameter of 110-130 nanometers. All are enveloped in a [[lipid]] (fat) membrane. Viewed in cross-section, they show grainy particles that are [[ribosomes]] acquired from their [[host]] cells. It is this characteristic that gave them their name, derived from the Latin "arena", which means "sandy". Their [[genome]], or genetic material, is composed of [[RNA]] only, and while their replication strategy is not completely understood, we know that new viral particles, called [[virions]], are created by [[budding]] from the surface of their [[hosts]]' cells.
[[File:Lassa fever micro.png|none|thumb|500px|Outbreak Distribution Map Lassa Fever CDC.png<SMALL><SMALL>''[http://www.cdc.gov/vhf/virus-families/arenaviridae.html]''<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url =  http://www.cdc.gov}}</ref></SMALL></SMALL>]]
===History of Arenaviridae===
* The first [[Arenavirus]], [[Lymphocytic choriomeningitis virus]] ([[LCMV]]), was isolated in 1933 during a study of an epidemic of [[St. Louis encephalitis]]. Although not the cause of the outbreak, [[LCMV]] was found to be a cause of aseptic (nonbacterial) [[meningitis]]. By the 1960s, several similar [[viruses]] had been discovered and they were classified into the new family [[Arenaviridae]]. Since [[Tacaribe]] virus was found in 1956, new [[Arenavirus]] have been discovered on the average of every one to three years. A number of [[Arenavirus]] have been isolated in rodents only, but few cause [[hemorrhagic disease]]. [[Junin virus]], isolated in 1958, was the first of these to be recognized. This [[virus]] causes Argentine [[hemorrhagic fever]] in a limited agrigultural area of the pampas in Argentina. Several years later, in 1963, in the remote savannas of the Beni province of Bolivia, Machupo virus was isolated. The next member of the virus family to be associated with an outbreak of human illness was Lassa virus in Nigeria in 1969. The most recent additions to these human pathogenic viruses were Guanarito detected in Venezuela in 1989, Sabia in Brazil in 1993, Chapare in Bolivia in 2004, and Lujo in South Africa in 2008.
===Structure and genome===
===Structure and genome===
* Lassa viruses are enveloped, [[single-stranded]], bisegmented, ambisense [[RNA viruses]]. Their genome<ref name="pmid10615121">{{cite journal| author=| title=Genome:The autobiography of a species in 23 chapters | journal=Nat Genet | year= 2000 | volume= 24 | issue= 1 | pages= 21 | pmid=10615121 | doi=10.1038/71638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10615121  }} </ref> is contained in two RNA segments that code for two proteins each, one in each sense, for a total of four viral proteins.<ref name="pmid17143722">{{cite journal| author=Moshkoff DA, Salvato MS, Lukashevich IS| title=Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. | journal=Virus Genes | year= 2007 | volume= 34 | issue= 2 | pages= 169-76 | pmid=17143722 | doi=10.1007/s11262-006-0050-3 | pmc=PMC1892610 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17143722  }} </ref> The large segment encodes a small zinc-binding protein (Z) that regulates transcription and replication,<ref name="pmid11533204">{{cite journal| author=Cornu TI, de la Torre JC| title=RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. | journal=J Virol | year= 2001 | volume= 75 | issue= 19 | pages= 9415-26 | pmid=11533204 | doi=10.1128/JVI.75.19.9415-9426.2001 | pmc=PMC114509 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11533204  }} </ref><ref name="pmid9281522">{{cite journal| author=Djavani M, Lukashevich IS, Sanchez A, Nichol ST, Salvato MS| title=Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. | journal=Virology | year= 1997 | volume= 235 | issue= 2 | pages= 414-8 | pmid=9281522 | doi=10.1006/viro.1997.8722 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9281522  }} </ref> and the [[RNA polymerase]] (L). The small segment encodes the [[nucleoprotein]] (NP) and the surface [[glycoprotein precursor]] ([[GP]], also known as the viral spike), which is proteolytically cleaved into the [[envelope]] [[glycoproteins]] [[GP1]] and [[GP2]] that bind to the alpha-dystroglycan [[receptor]] and mediate [[host]] cell entry.<ref name="pmid11119613">{{cite journal| author=Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H et al.| title=Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. | journal=J Virol | year= 2001 | volume= 75 | issue= 1 | pages= 448-57 | pmid=11119613 | doi=10.1128/JVI.75.1.448-457.2001 | pmc=PMC113937 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11119613  }} </ref>
* Lassa viruses are enveloped, [[single-stranded]], bisegmented, ambisense [[RNA viruses]]. Their genome<ref name="pmid10615121">{{cite journal| author=| title=Genome:The autobiography of a species in 23 chapters | journal=Nat Genet | year= 2000 | volume= 24 | issue= 1 | pages= 21 | pmid=10615121 | doi=10.1038/71638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10615121  }} </ref> is contained in two RNA segments that code for two proteins each, one in each sense, for a total of four viral proteins.<ref name="pmid17143722">{{cite journal| author=Moshkoff DA, Salvato MS, Lukashevich IS| title=Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. | journal=Virus Genes | year= 2007 | volume= 34 | issue= 2 | pages= 169-76 | pmid=17143722 | doi=10.1007/s11262-006-0050-3 | pmc=PMC1892610 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17143722  }} </ref> The large segment encodes a small zinc-binding protein (Z) that regulates transcription and replication,<ref name="pmid11533204">{{cite journal| author=Cornu TI, de la Torre JC| title=RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. | journal=J Virol | year= 2001 | volume= 75 | issue= 19 | pages= 9415-26 | pmid=11533204 | doi=10.1128/JVI.75.19.9415-9426.2001 | pmc=PMC114509 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11533204  }} </ref><ref name="pmid9281522">{{cite journal| author=Djavani M, Lukashevich IS, Sanchez A, Nichol ST, Salvato MS| title=Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. | journal=Virology | year= 1997 | volume= 235 | issue= 2 | pages= 414-8 | pmid=9281522 | doi=10.1006/viro.1997.8722 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9281522  }} </ref> and the [[RNA polymerase]] (L). The small segment encodes the [[nucleoprotein]] (NP) and the surface [[glycoprotein precursor]] ([[GP]], also known as the viral spike), which is proteolytically cleaved into the [[envelope]] [[glycoproteins]] [[GP1]] and [[GP2]] that bind to the alpha-dystroglycan [[receptor]] and mediate [[host]] cell entry.<ref name="pmid11119613">{{cite journal| author=Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H et al.| title=Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. | journal=J Virol | year= 2001 | volume= 75 | issue= 1 | pages= 448-57 | pmid=11119613 | doi=10.1128/JVI.75.1.448-457.2001 | pmc=PMC113937 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11119613  }} </ref>
[[File:Lassa fever micro.png|none|thumb|500px|Outbreak Distribution Map Lassa Fever CDC.png<SMALL><SMALL>''[http://www.cdc.gov/vhf/virus-families/arenaviridae.html]''<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url =  http://www.cdc.gov}}</ref></SMALL></SMALL>]]
* [[Lassa fever]] causes hemorrhagic [[fever]] frequently shown by [[immunosuppression]]. Replication for [[Lassa virus]] is very rapid, while also demonstrating temporal control in replication.<ref name="pmid16629503">{{cite journal| author=Lashley FR| title=Emerging infectious diseases at the beginning of the 21st century. | journal=Online J Issues Nurs | year= 2006 | volume= 11 | issue= 1 | pages= 2 | pmid=16629503 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16629503  }} </ref> The first replication step is transcription of [[mRNA]] copies of the negative- or minus-sense genome. This ensures an adequate supply of viral proteins for subsequent steps of replication, as the NP and L proteins are translated from the [[mRNA]]. The positive- or plus-sense [[genome]], then makes viral complementary [[RNA]] (vcRNA)copies of itself. The [[RNA]] copies are a template for producing negative-sense progeny, but [[mRNA]] is also synthesized from it. The [[mRNA]] synthesized from [[vcRNA]] are translated to make the GP and Z proteins. This temporal control allows the spike proteins to be produced last, and therefore, delay recognition by the host [[immune system]].
* [[Lassa fever]] causes hemorrhagic [[fever]] frequently shown by [[immunosuppression]]. Replication for [[Lassa virus]] is very rapid, while also demonstrating temporal control in replication.<ref name="pmid16629503">{{cite journal| author=Lashley FR| title=Emerging infectious diseases at the beginning of the 21st century. | journal=Online J Issues Nurs | year= 2006 | volume= 11 | issue= 1 | pages= 2 | pmid=16629503 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16629503  }} </ref> The first replication step is transcription of [[mRNA]] copies of the negative- or minus-sense genome. This ensures an adequate supply of viral proteins for subsequent steps of replication, as the NP and L proteins are translated from the [[mRNA]]. The positive- or plus-sense [[genome]], then makes viral complementary [[RNA]] (vcRNA)copies of itself. The [[RNA]] copies are a template for producing negative-sense progeny, but [[mRNA]] is also synthesized from it. The [[mRNA]] synthesized from [[vcRNA]] are translated to make the GP and Z proteins. This temporal control allows the spike proteins to be produced last, and therefore, delay recognition by the host [[immune system]].
* [[Nucleotide]] studies of the [[genome]] have shown that Lassa has four lineages: three found in Nigeria and the fourth in Guinea, Liberia, and Sierra Leone. The Nigerian strains seem likely to have been ancestral to the others but additional work is required to confirm this.<ref name="pmid10888638">{{cite journal| author=Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH et al.| title=Genetic diversity among Lassa virus strains. | journal=J Virol | year= 2000 | volume= 74 | issue= 15 | pages= 6992-7004 | pmid=10888638 | doi= | pmc=PMC112216 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10888638  }} </ref> One book that explains about this disease is The Lassa Ward by Ross I. Donaldson. He describes what it is like being a doctor and taking care of the Sierra Leone people who have contracted the virus.
* [[Nucleotide]] studies of the [[genome]] have shown that Lassa has four lineages: three found in Nigeria and the fourth in Guinea, Liberia, and Sierra Leone. The Nigerian strains seem likely to have been ancestral to the others but additional work is required to confirm this.<ref name="pmid10888638">{{cite journal| author=Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH et al.| title=Genetic diversity among Lassa virus strains. | journal=J Virol | year= 2000 | volume= 74 | issue= 15 | pages= 6992-7004 | pmid=10888638 | doi= | pmc=PMC112216 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10888638  }} </ref> One book that explains about this disease is The Lassa Ward by Ross I. Donaldson. He describes what it is like being a doctor and taking care of the Sierra Leone people who have contracted the virus.
Line 45: Line 40:
* [[Dystroglycan]], which is later cleaved into [[alpha-dystroglycan]] and [[beta-dystroglycan]] is originally expressed in most [[cells]] to mature [[tissues]], and it provides molecular link between the [[ECM]] and the [[actin]]-based [[cytoskeleton]]<ref name="pmid18182084">{{cite journal| author=Rojek JM, Kunz S| title=Cell entry by human pathogenic arenaviruses. | journal=Cell Microbiol | year= 2008 | volume= 10 | issue= 4 | pages= 828-35 | pmid=18182084 | doi=10.1111/j.1462-5822.2007.01113.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18182084  }} </ref>. After [[virus]] enters the [[cell]] by [[alpha-dystroglycan]] mediated [[endocytosis]], low-[[pH]] environment triggers [[pH]]-dependent [[membrane fusion]] and releases [[RNP]] (viral [[ribonucleoprotein]]) complex into the [[cytoplasm]]. Viral [[RNA]] is unpacked, and [[replication]] and [[transcription]] initiate in the [[cytoplasm]].<ref name="pmid18182084">{{cite journal| author=Rojek JM, Kunz S| title=Cell entry by human pathogenic arenaviruses. | journal=Cell Microbiol | year= 2008 | volume= 10 | issue= 4 | pages= 828-35 | pmid=18182084 | doi=10.1111/j.1462-5822.2007.01113.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18182084  }} </ref> As the [[replication]] starts, both S and L [[RNA]] genomes synthesize the antigenomic S and L [[RNAs]], and from the antigenomic [[RNA]]s, genomic S and L [[RNA]] are synthesized. Both genomic and antigenomic RNAs are needed for [[transcription]] and [[translation]]. S [[RNA]] encodes [[GP]] and [[NP]] (viral [[nucleocapsid protein]]) [[proteins]], and L [[RNA]] encodes Z and L [[proteins]]. L [[protein]] most likely represents the viral RNA-dependent [[RNA polymerase]].<ref name="pmid12615304">{{cite journal| author=Drosten C, Kümmerer BM, Schmitz H, Günther S| title=Molecular diagnostics of [[viral hemorrhagic fevers]]. | journal=Antiviral Res | year= 2003 | volume= 57 | issue= 1-2 | pages= 61-87 | pmid=12615304 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12615304  }} </ref> When the [[cell]] is infected by the [[virus]], [[L polymerase]] is associated with the [[viral RNP]] and initiates the [[transcription]] of the [[genomic RNA]]. The 5’ and 3’ terminal 19 nt viral [[promoter]] regions of both [[RNA]] segments are necessary for recognition and binding of the [[viral polymerase]]. The primary [[transcription]] first transcribes [[mRNAs]] from the genomic S and L [[RNAs]], which code NP and L [[proteins]], respectively. [[Transcription]] terminates at the [[stem-loop]] (SL) structure within the intergenomic region. [[Arenaviruses]] use a cap snatching strategy to gain the cap structures from the cellular [[mRNAs]], and it is mediated by the [[endonuclease]] activity of the [[L polymerase]] and the cap binding activity of NP. [[Antigenomic RNA]] transcribes viral genes GPC and Z, encoded in genomic orientation, from S and L segments respectively. The [[antigenomic RNA]] also serves as the template for the replication.<ref name="pmid23202452">{{cite journal| author=Yun NE, Walker DH| title=Pathogenesis of Lassa fever. | journal=Viruses | year= 2012 | volume= 4 | issue= 10 | pages= 2031-48 | pmid=23202452 | doi=10.3390/v4102031 | pmc=PMC3497040 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23202452  }} </ref> After [[translation]] of GPC, it is posttranslationally modified in the [[endoplasmic reticulum]]. GPC is cleaved into [[GP1]] and [[GP2]] at the later stage of the secretory pathway. It is reported the cellular [[protease]] [[SKI-1]]/[[S1P]] was responsible for the [[cleavage]]. Cleaved [[glycoproteins]] are incorporated into the [[virion]] envelope when the [[virus]] buds and release from the [[cell membrane]].<ref name="pmid12615304">{{cite journal| author=Drosten C, Kümmerer BM, Schmitz H, Günther S| title=Molecular diagnostics of viral hemorrhagic fevers. | journal=Antiviral Res | year= 2003 | volume= 57 | issue= 1-2 | pages= 61-87 | pmid=12615304 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12615304  }} </ref>
* [[Dystroglycan]], which is later cleaved into [[alpha-dystroglycan]] and [[beta-dystroglycan]] is originally expressed in most [[cells]] to mature [[tissues]], and it provides molecular link between the [[ECM]] and the [[actin]]-based [[cytoskeleton]]<ref name="pmid18182084">{{cite journal| author=Rojek JM, Kunz S| title=Cell entry by human pathogenic arenaviruses. | journal=Cell Microbiol | year= 2008 | volume= 10 | issue= 4 | pages= 828-35 | pmid=18182084 | doi=10.1111/j.1462-5822.2007.01113.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18182084  }} </ref>. After [[virus]] enters the [[cell]] by [[alpha-dystroglycan]] mediated [[endocytosis]], low-[[pH]] environment triggers [[pH]]-dependent [[membrane fusion]] and releases [[RNP]] (viral [[ribonucleoprotein]]) complex into the [[cytoplasm]]. Viral [[RNA]] is unpacked, and [[replication]] and [[transcription]] initiate in the [[cytoplasm]].<ref name="pmid18182084">{{cite journal| author=Rojek JM, Kunz S| title=Cell entry by human pathogenic arenaviruses. | journal=Cell Microbiol | year= 2008 | volume= 10 | issue= 4 | pages= 828-35 | pmid=18182084 | doi=10.1111/j.1462-5822.2007.01113.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18182084  }} </ref> As the [[replication]] starts, both S and L [[RNA]] genomes synthesize the antigenomic S and L [[RNAs]], and from the antigenomic [[RNA]]s, genomic S and L [[RNA]] are synthesized. Both genomic and antigenomic RNAs are needed for [[transcription]] and [[translation]]. S [[RNA]] encodes [[GP]] and [[NP]] (viral [[nucleocapsid protein]]) [[proteins]], and L [[RNA]] encodes Z and L [[proteins]]. L [[protein]] most likely represents the viral RNA-dependent [[RNA polymerase]].<ref name="pmid12615304">{{cite journal| author=Drosten C, Kümmerer BM, Schmitz H, Günther S| title=Molecular diagnostics of [[viral hemorrhagic fevers]]. | journal=Antiviral Res | year= 2003 | volume= 57 | issue= 1-2 | pages= 61-87 | pmid=12615304 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12615304  }} </ref> When the [[cell]] is infected by the [[virus]], [[L polymerase]] is associated with the [[viral RNP]] and initiates the [[transcription]] of the [[genomic RNA]]. The 5’ and 3’ terminal 19 nt viral [[promoter]] regions of both [[RNA]] segments are necessary for recognition and binding of the [[viral polymerase]]. The primary [[transcription]] first transcribes [[mRNAs]] from the genomic S and L [[RNAs]], which code NP and L [[proteins]], respectively. [[Transcription]] terminates at the [[stem-loop]] (SL) structure within the intergenomic region. [[Arenaviruses]] use a cap snatching strategy to gain the cap structures from the cellular [[mRNAs]], and it is mediated by the [[endonuclease]] activity of the [[L polymerase]] and the cap binding activity of NP. [[Antigenomic RNA]] transcribes viral genes GPC and Z, encoded in genomic orientation, from S and L segments respectively. The [[antigenomic RNA]] also serves as the template for the replication.<ref name="pmid23202452">{{cite journal| author=Yun NE, Walker DH| title=Pathogenesis of Lassa fever. | journal=Viruses | year= 2012 | volume= 4 | issue= 10 | pages= 2031-48 | pmid=23202452 | doi=10.3390/v4102031 | pmc=PMC3497040 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23202452  }} </ref> After [[translation]] of GPC, it is posttranslationally modified in the [[endoplasmic reticulum]]. GPC is cleaved into [[GP1]] and [[GP2]] at the later stage of the secretory pathway. It is reported the cellular [[protease]] [[SKI-1]]/[[S1P]] was responsible for the [[cleavage]]. Cleaved [[glycoproteins]] are incorporated into the [[virion]] envelope when the [[virus]] buds and release from the [[cell membrane]].<ref name="pmid12615304">{{cite journal| author=Drosten C, Kümmerer BM, Schmitz H, Günther S| title=Molecular diagnostics of viral hemorrhagic fevers. | journal=Antiviral Res | year= 2003 | volume= 57 | issue= 1-2 | pages= 61-87 | pmid=12615304 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12615304  }} </ref>


==Vector==
==Natural Reservoir==
* The [[reservoir]], or [[host]], of Lassa virus is a [[rodent]] known as the "multimammate rat" (Mastomys natalensis). Once infected, this rodent is able to [[excrete]] [[virus]] in [[urine]] for an extended time period, maybe for the rest of its life. Mastomys rodents breed frequently, produce large numbers of offspring, and are numerous in the savannas and forests of west, central, and east Africa. In addition, Mastomys readily colonize human homes and areas where food is stored. All of these factors contribute to the relatively efficient spread of Lassa virus from [[infected]] [[rodents]] to [[humans]].
* The [[reservoir]], or [[host]], of Lassa virus is a [[rodent]] known as the "multimammate rat" (Mastomys natalensis). Once infected, this rodent is able to [[excrete]] [[virus]] in [[urine]] for an extended time period, maybe for the rest of its life. Mastomys rodents breed frequently, produce large numbers of offspring, and are numerous in the savannas and forests of west, central, and east Africa. In addition, Mastomys readily colonize human homes and areas where food is stored. All of these factors contribute to the relatively efficient spread of Lassa virus from [[infected]] [[rodents]] to [[humans]].
* [[Transmission]] of Lassa virus to humans occurs most commonly through [[ingestion]] or [[inhalation]]. Mastomysrodents shed the [[virus]] in [[urine]] and droppings and direct contact with these materials, through touching soiled objects, eating contaminated [[food]], or exposure to open [[cuts]] or [[sores]], can lead to [[infection]].
* [[Transmission]] of Lassa virus to humans occurs most commonly through [[ingestion]] or [[inhalation]]. Mastomysrodents shed the [[virus]] in [[urine]] and droppings and direct contact with these materials, through touching soiled objects, eating contaminated [[food]], or exposure to open [[cuts]] or [[sores]], can lead to [[infection]].
Line 55: Line 50:
<gallery>
<gallery>
Image:PHIL 2994 lores.jpg|This photomicrograph shows hepatitis caused by the Lassa virus, using toluidine-blue azure II stain. Source: CDC microbiologist Dr. W. Winn.<SMALL><SMALL>''[http://phil.cdc.gov/phil/details.asp  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/details.asp/}}</ref></SMALL></SMALL>
Image:PHIL 2994 lores.jpg|This photomicrograph shows hepatitis caused by the Lassa virus, using toluidine-blue azure II stain. Source: CDC microbiologist Dr. W. Winn.<SMALL><SMALL>''[http://phil.cdc.gov/phil/details.asp  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/details.asp/}}</ref></SMALL></SMALL>
Image:Ebola virus1.png|This transmission electron micrograph (TEM) demonstrates the ultrastructural morphologic changes in this tissue sample isolate.<SMALL><SMALL>''[http://phil.cdc.gov/phil/  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/}}</ref></SMALL></SMALL>
Image:Lassa virions.jpg|This highly magnified transmission electron micrograph (TEM) depicted some of the ultrastructural details of three Lassa virus virions.<SMALL><SMALL>''[http://phil.cdc.gov/phil/details.asp Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/details.asp}}</ref></SMALL></SMALL>
Image:Ebola virus3.png|Scanning electron micrograph (SEM) revealing ultrastructural morphologic features of the Ebola virus from the Ivory Coast of Africa.<SMALL><SMALL>''[http://phil.cdc.gov/phil/  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/}}</ref></SMALL></SMALL>
Image:Ebola virus3.png|Scanning electron micrograph (SEM) revealing ultrastructural morphologic features of the Ebola virus from the Ivory Coast of Africa.<SMALL><SMALL>''[http://phil.cdc.gov/phil/  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/}}</ref></SMALL></SMALL>
Image:Ebola virus4.png|Negatively-stained transmission electron micrograph (TEM) demonstrating the ultrastructural curvilinear morphologic features displayed by the Ebola virus from the Ivory Coast of Africa.<SMALL><SMALL>''[http://phil.cdc.gov/phil/  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/}}</ref></SMALL></SMALL></gallery>
Image:Ebola virus4.png|Negatively-stained transmission electron micrograph (TEM) demonstrating the ultrastructural curvilinear morphologic features displayed by the Ebola virus from the Ivory Coast of Africa.<SMALL><SMALL>''[http://phil.cdc.gov/phil/  Adapted from Public Health Image Library (PHIL), Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://phil.cdc.gov/phil/}}</ref></SMALL></SMALL></gallery>

Revision as of 01:14, 6 June 2015

style="background:#Template:Taxobox colour;"|Lassa Virus (LASV)
TEM micrograph of Lassa virus virions.
TEM micrograph of Lassa virus virions.
style="background:#Template:Taxobox colour;" | Virus classification
Group: Group V ((-)ssRNA)
Order: Unassigned
Family: Arenaviridae
Genus: Arenavirus
Species: Lassa virus

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever causes

CDC on Lassa fever causes

Lassa fever causes in the news

Blogs on Lassa fever causes

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [4]

Synonyms and keywords: Lassa hemorrhagic fever; LHF

Overview

Lassa fever is caused by the Lassa virus, a member of the Arenaviridae family. It is an enveloped, single-stranded, bisegmented RNA virus. Mastomysrodents shed the virus in urine and droppings. The direct contact with these materials or ingestion or inhalation, can lead to infection. Lassa virus enters the cell by the receptor-mediated endocytosis and undergoes very rapid replication and manifest the disease.

Virus

Taxonomy

Biology

  • Lassa virus belongs to Arenaviridae [2].
  • The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted diseases in humans. Each virus usually is associated with a particular rodent host species in which it is maintained. Arenavirus infections are relatively common in humans in some areas of the world and can cause severe illnesses.

Structure and genome

Outbreak Distribution Map Lassa Fever CDC.png[1][8]
  • Lassa fever causes hemorrhagic fever frequently shown by immunosuppression. Replication for Lassa virus is very rapid, while also demonstrating temporal control in replication.[9] The first replication step is transcription of mRNA copies of the negative- or minus-sense genome. This ensures an adequate supply of viral proteins for subsequent steps of replication, as the NP and L proteins are translated from the mRNA. The positive- or plus-sense genome, then makes viral complementary RNA (vcRNA)copies of itself. The RNA copies are a template for producing negative-sense progeny, but mRNA is also synthesized from it. The mRNA synthesized from vcRNA are translated to make the GP and Z proteins. This temporal control allows the spike proteins to be produced last, and therefore, delay recognition by the host immune system.
  • Nucleotide studies of the genome have shown that Lassa has four lineages: three found in Nigeria and the fourth in Guinea, Liberia, and Sierra Leone. The Nigerian strains seem likely to have been ancestral to the others but additional work is required to confirm this.[10] One book that explains about this disease is The Lassa Ward by Ross I. Donaldson. He describes what it is like being a doctor and taking care of the Sierra Leone people who have contracted the virus.
Lassa Fever wikipedia.png[2][8]

Receptors

Life cycle

Natural Reservoir

  • The reservoir, or host, of Lassa virus is a rodent known as the "multimammate rat" (Mastomys natalensis). Once infected, this rodent is able to excrete virus in urine for an extended time period, maybe for the rest of its life. Mastomys rodents breed frequently, produce large numbers of offspring, and are numerous in the savannas and forests of west, central, and east Africa. In addition, Mastomys readily colonize human homes and areas where food is stored. All of these factors contribute to the relatively efficient spread of Lassa virus from infected rodents to humans.
  • Transmission of Lassa virus to humans occurs most commonly through ingestion or inhalation. Mastomysrodents shed the virus in urine and droppings and direct contact with these materials, through touching soiled objects, eating contaminated food, or exposure to open cuts or sores, can lead to infection.
  • Because Mastomys rodents often live in and around homes and scavenge on leftover human food items or poorly stored food, direct contact transmission is common. Mastomys rodents are sometimes consumed as a food source and infection may occur when rodents are caught and prepared. Contact with the virus may also occur when a person inhales tiny particles in the air contaminated with infected rodent excretions. This aerosol or airborne transmission may occur during cleaning activities, such as sweeping.
  • Direct contact with infected rodents is not the only way in which people are infected; person-to-person transmission may occur after exposure to virus in the blood, tissue, secretions, or excretions of a Lassa virus-infected individual. Casual contact (including skin-to-skin contact without exchange of body fluids) does not spread Lassa virus. Person-to-person transmission is common in health care settings (called nosocomial transmission) where proper personal protective equipment (PPE) is not available or not used. Lassa virus may be spread in contaminated medical equipment, such as reused needles.

Gallery

The images below display key features of the Lassa virus.

References

  1. "Taxonomy browser (Lassavirus)".
  2. "The Centers for Disease Control and Prevention".
  3. "Genome:The autobiography of a species in 23 chapters". Nat Genet. 24 (1): 21. 2000. doi:10.1038/71638. PMID 10615121.
  4. Moshkoff DA, Salvato MS, Lukashevich IS (2007). "Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses". Virus Genes. 34 (2): 169–76. doi:10.1007/s11262-006-0050-3. PMC 1892610. PMID 17143722.
  5. Cornu TI, de la Torre JC (2001). "RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome". J Virol. 75 (19): 9415–26. doi:10.1128/JVI.75.19.9415-9426.2001. PMC 114509. PMID 11533204.
  6. Djavani M, Lukashevich IS, Sanchez A, Nichol ST, Salvato MS (1997). "Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End". Virology. 235 (2): 414–8. doi:10.1006/viro.1997.8722. PMID 9281522.
  7. Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H; et al. (2001). "Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics". J Virol. 75 (1): 448–57. doi:10.1128/JVI.75.1.448-457.2001. PMC 113937. PMID 11119613.
  8. 8.0 8.1 "Center for Disease Control and Prevention (CDC)".
  9. Lashley FR (2006). "Emerging infectious diseases at the beginning of the 21st century". Online J Issues Nurs. 11 (1): 2. PMID 16629503.
  10. 10.0 10.1 Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH; et al. (2000). "Genetic diversity among Lassa virus strains". J Virol. 74 (15): 6992–7004. PMC 112216. PMID 10888638.
  11. "Wikipedia lassa virus".
  12. 12.0 12.1 Rojek JM, Kunz S (2008). "Cell entry by human pathogenic arenaviruses". Cell Microbiol. 10 (4): 828–35. doi:10.1111/j.1462-5822.2007.01113.x. PMID 18182084.
  13. 13.0 13.1 Drosten C, Kümmerer BM, Schmitz H, Günther S (2003). "Molecular diagnostics of [[viral hemorrhagic fevers]]". Antiviral Res. 57 (1–2): 61–87. PMID 12615304. URL–wikilink conflict (help)
  14. Yun NE, Walker DH (2012). "Pathogenesis of Lassa fever". Viruses. 4 (10): 2031–48. doi:10.3390/v4102031. PMC 3497040. PMID 23202452.
  15. 15.0 15.1 15.2 15.3 "Public Health Image Library (PHIL), Centers for Disease Control and Prevention".


Template:WikiDoc Sources